MTD · Mettler-Toledo International Inc.
$1263.752026-07-21Sector: Healthcare; Industry: Medical - Diagnostics & Research; Sub-Industry: Life Sciences Tools & Services
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$643
-49.1% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($602 · $779) Analysts Range ($1194 · $1500) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $3.8B | — | 28.5% | 19.6% | $868MM | $117MM | $985MM | 9.5% | — | 46.7% | $1.9B | $38.88 | — |
| 2024.Q4 | $3.8B | 0.0% | 28.5% | 16.8% | $898MM | $8MM | $906MM | 10.6% | — | 48.4% | $1.9B | $38.88 | — |
| 2025.Q1 | $3.9B | 2.2% | 29.1% | 16.6% | $940MM | $1MM | $940MM | 10.2% | — | 51.0% | $1.8B | $42.55 | — |
| 2025.Q4 | $3.9B | 0.0% | 29.1% | 17.1% | $934MM | −$174MM | $760MM | 10.7% | — | 46.7% | $2.2B | $42.55 | — |
| 2026.Q1 | $4.1B | 5.6% | 28.0% | 17.2% | $948MM | −$246MM | $702MM | 9.9% | — | 44.1% | $2.1B | $43.14 | 22.4 |
| italics below = DCF projection · 10yr Rev CAGR: 4.9% |
| 2027.Q1 | $4.3B | +4.7% | 28.0% | 17.5% | $989MM | −$102MM | $886MM | 9.6% | $809MM | 45.4% | $2.2B | $48.72 | 25.9 |
| 2028.Q1 | $4.5B | +4.8% | 28.0% | 17.8% | $1.0B | −$111MM | $922MM | 9.5% | $768MM | 45.2% | $2.3B | $50.91 | 24.8 |
| 2029.Q1 | $4.7B | +5.2% | 28.0% | 18.0% | $1.1B | −$126MM | $956MM | 9.4% | $728MM | 45.1% | $2.5B | $53.38 | 23.7 |
| 2030.Q1 | $5.0B | +4.9% | 28.0% | 18.3% | $1.1B | −$127MM | $1.0B | 9.3% | $700MM | 44.8% | $2.6B | $55.81 | 22.6 |
| 2031.Q1 | $5.2B | +5.6% | 28.0% | 18.6% | $1.2B | −$155MM | $1.0B | 9.2% | $661MM | 44.6% | $2.7B | $58.76 | 21.5 |
|
| Term. Yr+ | $6.9B | 4.1% | 21.4% | 20.0% | $1.2B | −$204MM | $969MM | 8.6% | $9.0B | 23.6% | — | — | — |
Active scenario IV: $643 (-49.1% vs market)